Maximus Beats Q2 EPS, Raises Full-Year Guidance, and Authorizes $400M Share Repurchase
MMS is trading near its 52-week low of $60.75 (5.8% above the low).
Summary
Maximus reported strong Q2 earnings, beat analyst estimates, raised its full-year guidance, and authorized a new $400 million share repurchase program.
Key Events · Earnings and Guidance · MMS
-
Strong Q2 Earnings Beat
Maximus reported adjusted diluted EPS of $2.07 for the second quarter, exceeding the analyst consensus of $1.97. Operating and adjusted EBITDA margins also expanded year-over-year.
-
Raised Full-Year Guidance
The company increased its adjusted EBITDA margin expectation by 20 basis points to approximately 14.2% and raised its adjusted diluted EPS outlook by $0.20 to a range of $8.25 to $8.55 for fiscal year 2026.
-
New $400 Million Share Repurchase Program
The Board of Directors authorized a refresh of the share repurchase program for up to an aggregate of $400 million, effective May 11, 2026. This follows $150.9 million in share repurchases already executed this quarter and through May 1.
Analysis · MMS · Trade & Services
Maximus delivered strong second-quarter results, surpassing analyst expectations for adjusted EPS and demonstrating improved operating margins. The company's decision to raise its full-year adjusted EBITDA margin and adjusted diluted EPS guidance signals increased confidence in its operational efficiency and future profitability. Furthermore, the authorization of a substantial $400 million share repurchase program, following significant repurchases already executed, underscores management's commitment to enhancing shareholder value and reflects a positive outlook on the company's valuation. This combination of strong performance, an improved outlook, and a significant capital return initiative is highly impactful for investors.
At the time of this filing, MMS was trading at $64.30 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $60.75 to $100.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.